Bibliografía de Suplementos Nutricionales

Los suplementos para la articulaciones – BIBLIOGRAFIA
 

1)    Agarwal K.A., Tripathi C.D. (2011). Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study. Surg Endosc. 2011 Dec (12) 3805-10.

2)    Aggarwal B.B., Shishodia S. (2004). Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci. 2004 Dec (1030), 434-41.

3)    Arden N.K., Cro S. (2016). The effectof Vitamin D supplementation on knee osteoarthritis, the VIDEO study; a randomised control trial. Osteoarthritis Cartilage. 2016 Nov, vol.24 (11)1858-1866.

4)    Arslan F., Keogh B. (2010). TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010 (70), 420-2.

5)    Bahadori B., Uitz E. (2010). Omega-3 Fatty acids infusions as adjuvant therapy in rheumatoid arthritis. JPEN J Parenter Enteral Nutr 2010, (34), 151-5.

6)    Barrouin-Melo S.M., Anturaniemi J. (2016). Evaluating oxidative stress, serological- and haematological status of dogs suffering from osteoarthritis, after supplementing their diet with fish or corn oil. Lipids Health Dis. 2016 Aug vol.15 (1), 139.

7)    Belcaro G., Cesarone M.R. (2010). Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alternative Medicine Rev. 2010 Dec (4), 337-344

8)    Belcaro G., Cesarone M.R. (2010). Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med. 2010 Jun (2, Suppl 1), 55-62.

9)    Benito P., Monfort J. (2002). Efecto de los hidrolizados de colágeno sobre cultivos de condrocitos humanos. http://www.bagochile.cl/wp-content/uploads/2015/11/Benito-2002.pdf

10) Benito-Ruiz P., Camacho-Zambrano M.M. (2009). A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort. Int J Food Sci Nutr (2), 99–113.

11) Bischoff-Ferrari  H.A. (2004). Positive association between 25-hydroxy vitamin d levels and bone mineral density: a population-based study of younger and older adults.  Am J Med 2004, vol.116 (9) 634- 639.

12) Bischoff-Ferrari  H.A., Wong W.C. (2005). Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.  JAMA 2005, vol.293 (18), 2257- 2264.

13) Boe C., Vangsness C.T. (2015). Fish Oil and Osteoarthritis: Current Evidence. Am J Orthop (Belle Mead NJ). 2015 Jul, vol.44 (7), 302-5.

14) Boonen S., Lips P. (2007). Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007 Apr, vol.92 (4), 1415-23.

15) Braham R., Dawson B. (2003). The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med. 2003 Feb, vol.37(1), 45-9.

16) Buddhachat K., Siengdee P. (2017). Effects of different omega-3 sources, fish oil, krill oil, and green-lipped mussel against cytokine-mediated canine cartilage degradation. In Vitro Cell Dev Biol Anim. 2017 Jan.

17) Calamia V., Ruiz-Romero C. (2010). Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther 2010, vol.12 (4), 138.

18) Carmona L., Gabriel R. (2000). Proyecto EPISER 2000: prevalencia de enfermedades reumáticas en la población española. Revista Española Reumatología 2001 (28),18-25.

19) Carpenter T.O., DeLucia M.C. (2006). A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls. J Clin Endocrinol Metab. 2006 Dec, vol.91 (12), 4866-72.

20) Chen J.S., Hill C.L. (2016). Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial. Osteoporos Int. 2016 May, vol.27 (5), 1897-905

21) Chin K.Y. (2016). The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis. Drug Des Devel Ther. 2016 Sept (10), 3029-3042.

22) Clark K.L., Sebastianelli W. (2008). 24-week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin (24), 1485–1496.

23) Clegg D.O., Reda D.J. (2006). Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb, vol.354, (8), 795-808.

24) Daily J.W., Yang M. (2016). Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Journal Medical Food. 2016-Aug (8), 717-29.

25) Dasilva G., Pazos M. (2017). A lipidomic study on the regulation of inflammation and oxidative stress targeted by marine ω-3 PUFA and polyphenols in high-fat high-sucrose diets. J Nutr Biochem. 2017 Feb (43), 53-67.

26) Di Pierro F., Rapacioli G. (2013). Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva(®)), nimesulide, and acetaminophen.  J Pain Res. 2013 (6), 201-5.

27) Díaz Ortega J.L., Vera Granada C.J. (2012). Bases moleculares de los derivados metabólicos de ácidos omega-3 en el proceso antiinflamatorio. UCV – Scientia, vol.4 (2), 175-183.

28) EFSA Panel on Dietetic Products, Nutrition and Allergies (2011). Scientific Opinion on the substantiation of a health claim related to collagen hydrolysate and maintenance of joints pursuant. EFSA Journal, vol.9 (7), 2291.

29) Fransen M., Agaliotis M. (2014). Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015 May, vol.74 (5), 851-8.

30) Fujioka S., Hamazaki K. (2006). The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects–A randomized, placebo-controlled, double-blind study. J Nutr Sci Vitaminol 2006 Aug, vol.52 (4), 261-5.

31) Galluccio F., Barskova T. (2015). Short-term effect of the combination of hyaluronic acid, chondroitin sulfate, and keratin matrix on early symptomatic knee osteoarthritis. Eur J Rheumatol. 2015 Sep, vol.2 (3), 106-108.

32) Gan R.W., Demoruelle M.K. (2016). Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis. Ann Rheum Dis. 2017 Jan, vol.76 (1), 147-152.

33) Goldring M.B. (2006). Update on the biology of the chondrocytes and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol (20), 1003–1025.

34) Goldring M.B., Goldring S.R. (2007). Osteoarthritis. Journal of Cellular Physiology 2007 (213), 626-634.

35) Grosby V., Wilcock A. (2000). The safety and efficacy as a single (500mg or 1g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. Journal of Pain and Symptom Management 2000, (19) 35–9.

36) Hatayama T., Nagano M. (2008). The effect of a supplement on knee pain and discomfort evaluated by visual analogue scale (VAS): a randomized, double-blind, placebo-controlled study. Kenko-shien 2008, (10), 13–7.

37) Henrotin Y., Clutterbuck A.L. (2010). Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage 2010 (18), 141-149.

38) Herrero-Beaumont G., Ivorra JA. (2007). Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 2007, (56), 555-67.

39) Hin H., Tomson J., (2016) Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care. Osteoporos Int. 2017; vol.28 (3), 841–851.

40) Hisada N., Satsu H. (2008). Low-Molecular-Weight Hyaluronan Permeates through Human Intestinal Caco-2 Cell Monolayers via the Paracellular Pathway. Biosci Biotechnol Biochem. 2008, (72), 1111–4.

41) Hochberg M., Martel-Pelletier J. (2016). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016 Jan, vol.75 (1), 37-44.

42) Ierna M., Kerr A. (2010). Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskelet Disord 2010, vol.29 (11), 136.

43) Innis S.M. (2008). Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008 Oct, (1237), 35-43.

44) Ishibashi G., Yamagata T., (2002). Digestion and fermentation of hyaluronic acid. Journal for the integrated study of dietary habits 2002, vol.13 (2),107–11.

45) Jensen G.S., Attridge V.L. (2015). Oral intake of a liquid high-molecular-weight hyaluronan associated with relief of chronic pain and reduced use of pain medication: results of a randomized, placebo-controlled double-blind pilot study. Journal Med Food. 2015 (18), 95–101.

46) Jin X., Jones G. (2016). Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2016 Mar, vol.315 (10), 1005-13.

47) Johnson L.E. (2016). Vitamin D: The Merck Manual of Diagnosis and Therapy. Last full review/revision February 2016. http://www.msdmanuals.com/professional/nutritional-disorders/vitamin-deficiency,-dependency,-and-toxicity/vitamin-d

48) Jomphe C., Gabriac M., (2008). Chondroitin sulfate inhibits the nuclear translocation of NF-κB in IL-1β stimulated chondrocytes. Basic Clin Pharmacol Toxicol 2008 Jan (102), 59-65.

49)  Kelley D.S., Taylor P.C. (1999). Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids. 1999 Apr, vol.34 (4), 317-24.

50) Kim J., Lim S.Y. (2009). Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer 2009 Jun, (9), 216.

51) Kooshki A., Taleban F.A. (2011). Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients. Ann Nutr Metab. 2011, vol.58 (3), 197-202.

52) Koptniratsaikul V., Thanakhumton S. (2009). Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. Journal Altern. Complement Med. 2009 Aug (8), 891-897.

53) Krasnokutsky S., Samuels J. (2007). Osteoarthritis in 2007. Bull NYU Hospital Joints Disease 2007 (65), 222-228.

54) Kris-Etherton P.M., Harris W.S. (2002). Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease”, Circulation 2002, (106) 2747-2757.

55) Kurihara H., Kawada C., (2014). Absorption and effect on the skin of oral hyaluronan. Nutrition Journal 2014, (13) 70.

56) Kuriki K., Wakai K. (2006). Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids. Cancer Epidemiol Biomarkers Prev. 2006 Oct, vol.15 (10), 1791-8.

57) Kwan T.S., Pelletier J.P. (2007). Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study. Arthritis Res Ther. 2007 Nov (9), 117.

58) Laakhan S.E., Ford C.T. (2015). Zingiberaceae extracts for pain: a systematic review and meta-analysis. Nutrition Journal 2015 May (14) 50.

59) Lieberman S. (2007). The REAL Vitamin and Mineral Book. Penguin Group. 93-99.

60) López-Armada M.J., Carames B. (2004). Fisiopatología de la artrosis. ¿Cuál es la actualidad?. Revista Española Reumatología 2004 (31), 379-93.

61) Martel-Pelletier J., Farran A. (2015). Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. Molecules 2015 (3), 4277- 4289.

62) McAlindon T., LaValley M. (2007). Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA. 2013 Jan, vol.309 (2), 155-62.

63) MedlinePlus. (2015). Magnesio. Biblioteca Nacional de Medicina de EEUU. Last full review: February, 2015 http://web.archive.org/web/20151005200024/https://www.nlm.nih.gov/medlineplus/spanish/druginfo/natural/998.html

64) Mehler S.J., May L.R. (2016). A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 2016 Jun, (109), 1-7.

65) Mezquita P., Muñoz M. (2002). Elevada prevalencia de déficit de vitamina D en poblaciones con riesgo de osteoporosis: un factor relevante en la integridad ósea. Medicina Clínica, vol.119 (3), 85.

66) Möller I., Martinez-Puig D. (2009). Oral administration of a natural extract rich in hyaluronic acid for the treatment of knee OA with synovitis: a retrospective cohort study. Clin Nutr Suppl. 2009, (4), 171–2.

67) Monfort J., Pelletier J.P. (2008). Biochemical basis of the effect of chondroitin sulfate on osteoarthritis articular tissues. Ann Rheum Dis 2008 Jun (67), 735-40.

68) Mongil E., Sánchez I. (2006). Osteoartrosis Symptomatic slow acting drugs for osteoarthritis (Sysadoa). Rev. Soc. Esp. Dolor, vol.13 (7)

69) Moskowitz R.W. (2000). Role of collagen hydrolysate in bone and joint disease. Semin Arthritis Rheum, (30), 87–99.

70) Naito K., Watari T. (2010). Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. Elsevier, vol. 86, (13–14), 538–543

71) National Institute for Health and Clinical Excellence (2014). Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. National Clinical Guideline Centre (UK). London: National Institute for Health and Care Excellence (UK) 2014 Jul.

72) National Institutes of Health (2016). Omega-3 Fatty Acids. Office of Dietary Suplplements. U.S. Department of Health & Human Services. November 2, 2016  https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/

73) Nelson F.R., Zvirbulis R.A. (2015). The effects of an oral preparation containing hyaluronic acid (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses. Rheumatol Int. 2015, (35), 43–52.

74) Nemets B. (2002). Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder. Am. J. Psychiatry, (159) 477-479,

75) Nurtjahja-Tjendraputra E., Ammit AJ. (2003). Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res 2003 (111), 259–265.

76) Oesser S., Seifert J. (2003). Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen. Cell Tissue Res (311), 393–399.

77) Palermo N.E., Holick M.F. (2014). Vitamin D, bone health, and other health benefits in pediatric patients. J Pediatr Rehabil Med. 2014, vol.7 (2), 179-92.

78) Palmer D.J., Sullivan T. (2012). Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants’ allergies in first year of life: randomised controlled trial. BMJ 2012, 344.

79) Pavelka K., Bucsi L, (1998). Double-blind, dose-effect study of oral CS 1200 mg, 800 mg, 200 mg against placebo in the treatment of femoro-tibial osteoarthritis. Litera Rheumatologica 1998, (24) 21-30.

80) Pelletier J.P., Raynauld J.P. (2016). Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study. Arthritis Research & Therapy 2016 (18), 256.

81) Pinsornsak P., Niempoog S. (2012). The efficacy of Curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: A randomized control trial. Journal Medical Association Thai 2012 (95) Suppl 1, 51-58.

82) Reginster J.Y. (2001). Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 2001 Jan, vol.357 (9252), 251-6.

83) Reginster J.Y. (2014). Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind randomised, placebo-controlled trial. Ann Rheum Dis. 2014 Feb, vol.73 (2)

84) Ricci M., Micheloni G.M. (2016). Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis. Musculoskelet Surg. 2016 Sep.

85) Roman-Blas J.A., Jimenez S.A. (2006). NF-kB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage, (14),  839–848.

86) Rubio-Terres C., Moller-Parera I. (2004). Pharmacoeconomic análisis of artrosis treatment with chondroitin sulfate in comparison to NSAIDs. Atencion farmaceutica 2004, vol. 6 (1),15-27

87) Sato T., Iwaso H. (2009). An Effectiveness study of hyaluronic acid Hyabest® (J) in the treatment of osteoarthritis of the knee on the patients in the United State. Journal New Rem & Clin. 2009, (58), 551–8.

88)  Sawitzke A.D., Shi H. (2010). Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis. 2010 Aug vol.69 (8),1459-64.

89) Shakibaei M., John T. (2007). Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007 May (9), 1434-45.

90) Simopoulos A.P. (2007). Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002 (216), 495-505.

91) Singh J.A., Noorbaloochi S., (2015). Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015 (1), CD005614.

92) Souich P., Garcia A.G. (2009). Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009 (8A), 1451–63.

93) Stoll A.L., Damico K.E. (2001). Methodological considerations in clinical studies of omega 3 fatty acids in major depression and bipolar disorder. World Rev Nutr Diet. 2001, (88), 58-67.

94) Tat SK, Pelletier JP, (2007). Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts. Arthritis Res Ther. 2007;9:R117.

95) Terencio M.C., Ferrándiz M.L. (2016). Chondroprotective effects of the combination chondroitin sulfate-glucosamine in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats.  Biomed Pharmacother. 2016 Apr, (79), 120-8.

96)  Trč T., Bohmová J. (2011). Efficacy and tolerance of enzymatic hydrolysed collagen vs. glucosamine sulphate in the treatment of knee osteoarthritis. Int Orthop. 2011 Mar, vol.35 (3), 341–348.

97) Tsao Y.T., Shih Y.Y. (2017). Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells. Stem Cell Res Ther. 2017 Feb vol.28 (1), 39.

98) Uebelhart D., Malaise M. (2004). Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis and Cartilage 2004, vol.12 (4), 269-276.

99) Valenzuela R., Tapia G. (2011). Ácidos grasos omega-3 (EPA y DHA) y su aplicación en diversas situaciones clínicas. Rev Chil Nutr Vol.38 (3), 356-367.

100)                Wandel S., Jüni P. (2010). Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010, (341), 4675.

101)                Yousef A.A., Al-deeb A.E. (2013). A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia. 2013 Mar, vol.68 (3), 260-6.

102)                Zdzieblik D., Oesser E. (2015). Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial. Br Journal Nutrition 2015 Oct, vol.114 (8), 1237–1245.

103)                Zeghichi-Hamri S., De Lorgeril M. (2010). Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats. Nutr Res 2010 (30), 849-57.

104)                Zeng C., Li Y. (2016). Analgesic effect and safety of single-dose intra-articular magnesium after arthroscopic surgery: a systematic review and meta-analysis. Sci Rep. 2016 (6), 38024.

105)                Zhang D., Huang C. (2011). Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts.. Respir Res. 2011 Nov (12) 154.

106)                Zhang F., Altorki N.K. (1999). Curcumin inhibits cyclooxygenase-2 transcription in bile acid and phorbol ester treated human gastrointestinal epithelial cells. Carcinogenesis, vol.20 (3), 445-451.

SUBIR